| Etoposide studied in …STUDIED_INderived200 of 1,198show all (up to 200) |
|---|
| → studied in | NCT04231877Phase 1 · active not recruiting Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Aggressive Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05675410Phase 3 · recruiting A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377540Phase 2 · recruiting MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406465Phase 2 · recruiting A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity · 1,198 trials list this drug (240 active) | — | — | Neuroendocrine Carcinoma,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738368Phase 2 · suspended Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia · 1,198 trials list this drug (240 active) | — | — | T Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227597Phase 1/Phase 2 · recruiting A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472517Phase 3 · recruiting DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544654Phase 3 · recruiting DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847190Phase 2 · recruiting Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline: Randomized Phase II Trial · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00092222Phase 2 · active not recruiting Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity · 1,198 trials list this drug (240 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03418038Phase 2 · recruiting Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · 1,198 trials list this drug (240 active) | — | — | Lymphoma,Hodgkin Lymphoma,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600686Phase 2 · active not recruiting Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Double-Expressor Lymphoma,High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843940Phase 1/Phase 2 · not yet recruiting A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35) · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04679012Phase 2 · active not recruiting Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation · 1,198 trials list this drug (240 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194044Phase 1 · recruiting Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes · 1,198 trials list this drug (240 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511562Phase 2 · completed Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981899Phase 1/Phase 2 · active not recruiting A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · 1,198 trials list this drug (240 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301076Phase 1 · recruiting Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) · 1,198 trials list this drug (240 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Acute Adult T-Cell Leukemia/Lymphoma,Chronic Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684368Phase 2 · recruiting A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT · 1,198 trials list this drug (240 active) | — | — | Mixed Germ Cell Tumor,Central Nervous System Nongerminomatous Germ Cell Tumor,Choriocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06564844Phase 3 · active not recruiting A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features · 1,198 trials list this drug (240 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155174Phase 2 · recruiting A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857934Phase 2 · completed Therapy for Children With Advanced Stage Neuroblastoma · 1,198 trials list this drug (240 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03182244Phase 3 · completed A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation · 1,198 trials list this drug (240 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583550Phase 2 · recruiting Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833839Phase 3 · not yet recruiting ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine Carcinoma · 1,198 trials list this drug (240 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02003222Phase 3 · active not recruiting Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia · 1,198 trials list this drug (240 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665856Phase 3 · completed Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02436707Phase 2 · active not recruiting Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04293562Phase 3 · recruiting A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations · 1,198 trials list this drug (240 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955261Phase 2 · recruiting A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia · 1,198 trials list this drug (240 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06077500Phase 1 · active not recruiting DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03004287Phase 2 · active not recruiting 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy · 1,198 trials list this drug (240 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03407144Phase 2 · active not recruiting Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) · 1,198 trials list this drug (240 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535166Phase 2 · recruiting Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma · 1,198 trials list this drug (240 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132113Phase 1 · active not recruiting DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers · 1,198 trials list this drug (240 active) | — | — | Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061535Phase 2 · recruiting Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · 1,198 trials list this drug (240 active) | — | — | Hepatoblastoma,Hepatocellular Malignant Neoplasm, Not Otherwise Specified,Childhood Hepatocellular Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05403723Phase 1 · suspended Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06449209Phase 2 · active not recruiting Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517137Phase 2 · active not recruiting Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study · 1,198 trials list this drug (240 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665765Phase 2 · active not recruiting Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Transformed B-Cell Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,Diffuse Large B-Cell Lymphoma Unclassifiable | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483282Phase 2 · recruiting A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06646276Phase 3 · recruiting A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS). · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00632853Phase 3 · completed Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01356290Phase 2 · recruiting Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759586Phase 3 · active not recruiting Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05091567Phase 3 · active not recruiting A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361395Phase 1 · active not recruiting First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092283Phase 3 · active not recruiting Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005128Phase 3 · active not recruiting A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949129Phase 2/Phase 3 · recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia · 1,198 trials list this drug (240 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04699838Phase 2 · active not recruiting Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05533775Phase 1/Phase 2 · recruiting A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | Mature B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07802821Phase 3 · not yet recruiting A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04803201Phase 2 · recruiting Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,Follicular Helper T-Cell Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02114229Phase 2 · active not recruiting Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors · 1,198 trials list this drug (240 active) | — | — | Rhabdoid Tumor,Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02582697Phase 3 · recruiting Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours · 1,198 trials list this drug (240 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712355Phase 3 · recruiting Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07720193Phase 3 · not yet recruiting A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC · 1,198 trials list this drug (240 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05298423Phase 3 · completed Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006) · 1,198 trials list this drug (240 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · 1,198 trials list this drug (240 active) | — | — | Neuroblastoma,Childhood Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03811002Phase 3 · active not recruiting Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · 1,198 trials list this drug (240 active) | — | — | Lung Large Cell Carcinoma,Lung Squamous Cell Carcinoma,Lung Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792948Phase 2 · active not recruiting Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia · 1,198 trials list this drug (240 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01959698Phase 1 · active not recruiting Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02911142Phase 1/Phase 2 · active not recruiting Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | B-Cell Neoplasm,Primary Effusion Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02176967Phase 3 · active not recruiting Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma · 1,198 trials list this drug (240 active) | — | — | Ganglioneuroblastoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016871Phase 2 · active not recruiting Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL · 1,198 trials list this drug (240 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03067181Phase 3 · recruiting Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors · 1,198 trials list this drug (240 active) | — | — | Germ Cell Tumor,Malignant Germ Cell Tumor,Childhood Extracranial Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · 1,198 trials list this drug (240 active) | — | — | Ganglioneuroblastoma,Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322318Phase 2 · recruiting A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT · 1,198 trials list this drug (240 active) | — | — | Anaplastic Kidney Wilms Tumor,Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05389423Phase 1 · recruiting Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas · 1,198 trials list this drug (240 active) | — | — | B-Cell Neoplasm,Non-Hodgkin Lymphoma,Burkitt Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05504291Phase 2 · recruiting A Study to Give Treatment Inside the Eye to Treat Retinoblastoma · 1,198 trials list this drug (240 active) | — | — | Retinoblastoma,Childhood Intraocular Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06368817Phase 2 · recruiting A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · 1,198 trials list this drug (240 active) | — | — | Germinoma,Pineal Region Germinoma,Suprasellar Germinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401330Phase 3 · recruiting A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) · 1,198 trials list this drug (240 active) | — | — | Mixed Cell Type Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059975early Phase 1 · recruiting UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML · 1,198 trials list this drug (240 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739758Phase 3 · recruiting A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946529Phase 2 · completed Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors · 1,198 trials list this drug (240 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Desmoplastic Small Round Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113500Phase 2 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Anaplastic Large Cell Lymphoma, ALK-Negative,Anaplastic Large Cell Lymphoma, ALK-Positive+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820957Phase 2/Phase 3 · active not recruiting Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body · 1,198 trials list this drug (240 active) | — | — | Ewing Sarcoma,High Grade Sarcoma,Round Cell Sarcoma with EWSR1-non-ETS Fusion+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741644Phase 1/Phase 2 · recruiting A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors · 1,198 trials list this drug (240 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521493Phase 3 · active not recruiting Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome · 1,198 trials list this drug (240 active) | — | — | Myelodysplastic Syndrome,Myeloid Leukemia Associated with Down Syndrome,Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 1,198 trials list this drug (240 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792253Phase 3 · recruiting Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07724457Phase 2/Phase 3 · not yet recruiting Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma · 1,198 trials list this drug (240 active) | — | — | Burkitt Lymphoma,High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719105early Phase 1 · recruiting Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma · 1,198 trials list this drug (240 active) | — | — | Aggressive NK-Cell Leukemia,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05624996Phase 3 · recruiting Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227584Phase 2 · recruiting ALL Backbone in AYAs · 1,198 trials list this drug (240 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768943Phase 2 · not yet recruiting GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662928Phase 2 · not yet recruiting Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study · 1,198 trials list this drug (240 active) | — | — | Adult Burkitt Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02227199Phase 1/Phase 2 · completed Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04924101Phase 2 · completed Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224100Phase 2 · recruiting Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma · 1,198 trials list this drug (240 active) | — | — | Lymphoblastic Lymphoma,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03440567Phase 1 · completed Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma,Mantle Cell Lymphoma,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220022Phase 1 · active not recruiting Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas · 1,198 trials list this drug (240 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03136146Phase 2 · recruiting Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia · 1,198 trials list this drug (240 active) | — | — | Acute Lymphoblastic Leukemia,Burkitt Leukemia,Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04947501early Phase 1 · active not recruiting A Study of N9 Chemotherapy in Children With Neuroblastoma · 1,198 trials list this drug (240 active) | — | — | Childhood Malignant Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01873326Phase 2 · active not recruiting Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors · 1,198 trials list this drug (240 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03984448Phase 2/Phase 3 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma,EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02443077Phase 3 · active not recruiting Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma Activated B-Cell Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05019716Phase 1/Phase 2 · recruiting Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma · 1,198 trials list this drug (240 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05058651Phase 2/Phase 3 · suspended Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung · 1,198 trials list this drug (240 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400946Phase 3 · completed 05-001: Treatment of Acute Lymphoblastic Leukemia in Children · 1,198 trials list this drug (240 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101853Phase 3 · active not recruiting Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia · 1,198 trials list this drug (240 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112916Phase 3 · active not recruiting Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma · 1,198 trials list this drug (240 active) | — | — | Childhood T Acute Lymphoblastic Leukemia,Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02166463Phase 3 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | Childhood Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306161Phase 3 · active not recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma · 1,198 trials list this drug (240 active) | — | — | Ewing Sarcoma,Peripheral Primitive Neuroectodermal Tumor of Bone,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141359Phase 2 · active not recruiting Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595424Phase 2 · active not recruiting Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas · 1,198 trials list this drug (240 active) | — | — | Gastric Neuroendocrine Carcinoma,Intestinal Neuroendocrine Carcinoma,Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07502300Phase 3 · recruiting A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07) · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379340Phase 3 · completed Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor · 1,198 trials list this drug (240 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06039371Phase 2 · recruiting Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study · 1,198 trials list this drug (240 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05821088Phase 2 · active not recruiting Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma,Gray-Zone Lymphoma,Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020030Phase 3 · active not recruiting Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents · 1,198 trials list this drug (240 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043872Phase 3 · active not recruiting Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583710Phase 3 · recruiting Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · 1,198 trials list this drug (240 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Central Nervous System Embryonal Tumor with Rhabdoid Features+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861573Phase 1/Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) · 1,198 trials list this drug (240 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04177004Phase 1 · active not recruiting Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant · 1,198 trials list this drug (240 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03591510Phase 2 · active not recruiting A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07321912Phase 2 · recruiting Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma · 1,198 trials list this drug (240 active) | — | — | Ewing Sarcoma,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049966Phase 1 · completed Atezolizumab in Large Cell Neuroendocrine Carcinoma · 1,198 trials list this drug (240 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06249191Phase 1/Phase 2 · recruiting Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma,High Grade B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03567642Phase 1 · active not recruiting A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04745689Phase 2 · active not recruiting Study of AZD2811 + Durvalumab in ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02094794Phase 2 · active not recruiting Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML · 1,198 trials list this drug (240 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06905509Phase 2 · recruiting Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,High Grade B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07009457Phase 1 · active not recruiting A Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01783535Phase 2 · active not recruiting Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma · 1,198 trials list this drug (240 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05312671Phase 2 · recruiting Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer · 1,198 trials list this drug (240 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00887159Phase 2 · completed A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642251Phase 1/Phase 2 · completed Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Neuroendocrine Carcinoma,Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02553460Phase 1/Phase 2 · active not recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I · 1,198 trials list this drug (240 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568994early Phase 1 · completed Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) · 1,198 trials list this drug (240 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06813079Phase 2 · recruiting Using Tumor Models to Determine Treatments · 1,198 trials list this drug (240 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871766Phase 2 · active not recruiting Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy · 1,198 trials list this drug (240 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 1,198 trials list this drug (240 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755804Phase 2 · active not recruiting Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 · 1,198 trials list this drug (240 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04702880Phase 2 · completed A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453154Phase 1/Phase 2 · completed Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02375204Phase 3 · active not recruiting Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors · 1,198 trials list this drug (240 active) | — | — | Germ Cell Tumor,Malignant Germ Cell Tumor,Mixed Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03983824Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia · 1,198 trials list this drug (240 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04728230Phase 1/Phase 2 · active not recruiting Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04833114Phase 3 · completed Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01993810Phase 3 · active not recruiting Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06497530Phase 2 · recruiting Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00534430Phase 2 · completed Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer · 1,198 trials list this drug (240 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544115Phase 2 · active not recruiting Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders · 1,198 trials list this drug (240 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01371981Phase 3 · completed Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 1,198 trials list this drug (240 active) | — | — | Myeloid Neoplasm,Myeloid Sarcoma,Leukemia Cutis+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883049Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations · 1,198 trials list this drug (240 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786783Phase 2 · completed Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · 1,198 trials list this drug (240 active) | — | — | Ganglioneuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04139304early Phase 1 · recruiting A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma · 1,198 trials list this drug (240 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02583893Phase 2 · completed Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia · 1,198 trials list this drug (240 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01840566Phase 1 · active not recruiting High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954805Phase 2 · recruiting Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) · 1,198 trials list this drug (240 active) | — | — | B-Cell Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077285Phase 2 · active not recruiting Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma · 1,198 trials list this drug (240 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00869232Phase 2 · active not recruiting UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission · 1,198 trials list this drug (240 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632708Phase 1 · active not recruiting Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation · 1,198 trials list this drug (240 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800587Phase 2 · recruiting Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02797470Phase 1/Phase 2 · active not recruiting Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant · 1,198 trials list this drug (240 active) | — | — | Adult Hodgkin Lymphoma,Adult Non-Hodgkin Lymphoma,Burkitt Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04380636Phase 3 · active not recruiting Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) · 1,198 trials list this drug (240 active) | — | — | Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05221645Phase 2 · active not recruiting Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017326Phase 3 · active not recruiting Paediatric Hepatic International Tumour Trial · 1,198 trials list this drug (240 active) | — | — | Hepatoblastoma,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528691Phase 2 · recruiting Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors · 1,198 trials list this drug (240 active) | — | — | Central Nervous System Neoplasm,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583511Phase 2 · recruiting Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00871013Phase 2 · active not recruiting Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy · 1,198 trials list this drug (240 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453500Phase 2 · active not recruiting Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia · 1,198 trials list this drug (240 active) | — | — | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06230224Phase 3 · active not recruiting A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04804007Phase 2 · recruiting Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT · 1,198 trials list this drug (240 active) | — | — | Germ Cell Tumor,Ovarian Germ Cell Tumor,Non-Seminomatous Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07296809Phase 2 · recruiting SKB500 Combinations in Patients With Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920932Phase 2 · active not recruiting Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06217757Phase 1/Phase 2 · recruiting Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Malignant Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00641381Phase 1 · completed Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma · 1,198 trials list this drug (240 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05815160Phase 1 · terminated Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01096368Phase 3 · completed Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma · 1,198 trials list this drug (240 active) | — | — | Anaplastic Ependymoma,Ependymoma,Brain Ependymoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206671Phase 3 · active not recruiting Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents · 1,198 trials list this drug (240 active) | — | — | Mature B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384015Phase 2 · active not recruiting Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05765825Phase 2 · active not recruiting Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05903092Phase 2 · recruiting MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06477523Phase 1/Phase 2 · active not recruiting Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06732258Phase 1 · withdrawn Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253435Phase 2 · completed N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma · 1,198 trials list this drug (240 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633514Phase 3 · withdrawn Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma · 1,198 trials list this drug (240 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06536868Phase 2 · recruiting Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03164057Phase 2 · active not recruiting A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia · 1,198 trials list this drug (240 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097363Phase 2 · recruiting Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma · 1,198 trials list this drug (240 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Burkitt Lymphoma,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07538258Phase 2 · not yet recruiting Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07538271Phase 2 · not yet recruiting A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864109Phase 2 · active not recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma · 1,198 trials list this drug (240 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605899Phase 3 · active not recruiting Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00864318Phase 2 · completed Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis · 1,198 trials list this drug (240 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106988Phase 2 · active not recruiting Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05595460Phase 1 · active not recruiting Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07525466Phase 1/Phase 2 · recruiting Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH) · 1,198 trials list this drug (240 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04560972Phase 1 · active not recruiting LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256421Phase 3 · completed A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793478Phase 1/Phase 2 · active not recruiting Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood · 1,198 trials list this drug (240 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692452Phase 2 · withdrawn Tazemetostat Plus CHOP in 1L T-cell Lymphoma · 1,198 trials list this drug (240 active) | — | — | Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type,Peripheral T-Cell Lymphoma, Not Otherwise Specified+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06769126Phase 2 · recruiting Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study · 1,198 trials list this drug (240 active) | — | — | Lung Small Cell Carcinoma,Lung Small Cell Carcinoma, A Subtype,Lung Small Cell Carcinoma, I Subtype+2 | 1 | Observed | clinicaltrials | graph → |